Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Hematological Malignancies
100%
Transplant Patients
100%
Haematopoietic Stem Cell Transplant Recipients
100%
Respiratory Viral Infection
100%
Ribavirin
66%
High Risk
33%
Immunocompromised Patients
33%
Prospective Clinical Trial
33%
Influenza Pneumonia
33%
Viral Infection
33%
High Incidence
33%
Antiviral Agents
33%
Enhanced Awareness
33%
Preventive Strategies
33%
Influenza-like Illness
33%
Patient Cells
33%
Antiviral Drugs
33%
Pneumonitis
33%
Infections In Immunocompromised Hosts
33%
Immunomodulator
33%
Respiratory Syncytial Virus Infection
33%
Lower Respiratory Tract
33%
Oseltamivir
33%
Infection Control Measures
33%
Zanamivir
33%
Neuraminidase Inhibitors
33%
Hematopoietic Cell Transplant
33%
Prolonged Viral Shedding
33%
Parainfluenza Virus Infections
33%
Antiviral Drug Resistance
33%
Strategy Awareness
33%
DAS181
33%
Pharmacology, Toxicology and Pharmaceutical Science
Hematologic Malignancy
100%
Viral Respiratory Tract Infection
100%
Infection
66%
Ribavirin
66%
Antiviral Drug
66%
Immunocompromised Patient
66%
Clinical Trial
33%
Retrospective Study
33%
Antivirus Agent
33%
Respiratory Tract
33%
Virus Infection
33%
Immunomodulating Agent
33%
Oseltamivir
33%
Sialidase Inhibitor
33%
Respiratory Syncytial Virus Infection
33%
Relenza
33%
Parainfluenza Virus Infection
33%
Medicine and Dentistry
Hematologic Malignancy
100%
Hematopoietic Cell
100%
Viral Respiratory Tract Infection
100%
Ribavirin
50%
Antiviral Drug
50%
Clinical Trial
25%
Infection
25%
Infection Control
25%
Retrospective Study
25%
Immunocompromised Patient
25%
Awareness
25%
Virus Infection
25%
Antiviral Resistance
25%
Immunomodulating Agent
25%
Infection in Immunocompromised Patients
25%
Respiratory Syncytial Virus Infection
25%
Lower Respiratory Tract
25%
Virus Shedding
25%
Zanamivir
25%
Oseltamivir
25%
Sialidase Inhibitor
25%
Parainfluenza Virus Infection
25%
Immunology and Microbiology
Hematopoietic Cell
100%
Viral Disease
100%
Infection
60%
Immunocompromised Patient
40%
Influenza
40%
Ribavirin
40%
Lower Respiratory Tract
20%
Antiviral Resistance
20%
Pneumonitis
20%
Awareness
20%
Immunomodulating Drug
20%
Respiratory Syncytial Virus Infection
20%
Relenza
20%
Paramyxovirinae
20%
Viral Shedding
20%
Neuraminidase Inhibitor
20%